Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

about

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes.

P2860

Q38708742-658C3799-C0A6-4A28-8F93-DF7F55F90CE3

P2860

Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Item

http://www.wikidata.org/entity/Q38770059

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Experimental Anti-Inflammatory ...... geting the TLR Chaperone gp96.

@en

type

Item

label

Experimental Anti-Inflammatory ...... geting the TLR Chaperone gp96.

@en

prefLabel

Experimental Anti-Inflammatory ...... geting the TLR Chaperone gp96.

@en

P1476

Experimental Anti-Inflammatory ...... geting the TLR Chaperone gp96.

@en

P2093

Anatoly V Grishin

http://www.w3.org/2001/XMLSchema#string

Jin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4

Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages

Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation

Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis

Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma.

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease.

Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability.

Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone

P304

5130-5137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1502135

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Henri R Ford

P577

2016-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27194788

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

molecular chaperones

P932

4896225

http://www.w3.org/2001/XMLSchema#string

Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

about

P2860

P2860

Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932